RESUMEN
Adult Refsum disease (ARD) is a rare peroxisomal biogenesis disorder inherited in an autosomal recessive fashion and is often characterized by retinitis pigmentosa, cerebellar ataxia, and polyneuropathy. Many patients with ARD require diet modification, psychosocial support, and various specialist visits to manage their symptoms. In this study, we explored the quality of life in individuals with ARD by analyzing retrospective survey data collected by the Coordination of Rare Diseases at Sanford (CoRDS) Registry and Global Defeat Adult Refsum Everywhere (DARE) Foundation. Statistical tests used were frequencies, mean, and median. There were 32 respondents, ranging between 11 and 32 responses for each question. The mean age at diagnosis was 35.5 ± 14.5 years (range 6-64) with 36.4% male and 63.6% female respondents. The average age for retinitis pigmentosa diagnosis was 22.8 ± 15.7 years (range 2-61). Dieticians were the most frequently seen (41.7%) for management of low-phytanic-acid diets. Most participants exercise at least once per week (92.5%). Depression symptoms were reported in 86.2% of the participants. Early diagnosis of ARD is important for managing symptoms and preventing progression of visual impairment due to phytanic acid buildup. Interdisciplinary approach should be used for patients to address physical and psychosocial impairments of ARD.
Asunto(s)
Enfermedad de Refsum , Retinitis Pigmentosa , Adulto , Humanos , Masculino , Femenino , Preescolar , Niño , Adolescente , Adulto Joven , Persona de Mediana Edad , Enfermedad de Refsum/diagnóstico , Ácido Fitánico , Estudios Retrospectivos , Calidad de Vida , Estilo de VidaAsunto(s)
Imagen por Resonancia Magnética/métodos , Enfermedad de Refsum/diagnóstico , Convulsiones/tratamiento farmacológico , Diagnóstico Diferencial , Humanos , Discapacidades para el Aprendizaje/diagnóstico , Discapacidades para el Aprendizaje/etiología , Masculino , Enfermedades Raras , Enfermedad de Refsum/diagnóstico por imagen , Medición de Riesgo , Convulsiones/diagnóstico , Convulsiones/etiología , Índice de Severidad de la Enfermedad , Adulto JovenRESUMEN
Introducción: Las ataxias espinocerebelosas de herencia recesiva constituyen un amplio grupo de enfermedades del cerebelo y/o de sus conexiones; en muchos casos también se afectan otras partes del sistema nervioso. Asimismo, y con cierta frecuencia, se acompañan de diversas manifestaciones sistémicas (cardiopatía, alteraciones cutáneas, endocrinopatías, malformaciones esqueléticas). Desarrollo: En este trabajo se revisan los conocimientos actuales sobre las principales ataxias recesivas de curso progresivo, con el fin de establecer unas claves que faciliten su complejo diagnóstico. Conclusiones: Una cuidadosa evaluación clínica (síndrome espinocerebeloso puro o plus con o sin manifestaciones sistémicas), acompañada de la determinación de ciertos marcadores de laboratorio (vitamina E, acantocitosis, alfa-fetoproteína, ácido láctico, albúmina, colesterol, ácido fitánico, coenzima-Q10, CK, colestanol, quitotriosidasa, cobre, ceruloplasmina), la valoración de los datos del estudio electroneuromiográfico (ausencia o presencia de neuropatía y tipo de la misma) y los hallazgos del estudio de resonancia magnética (ausencia o presencia de atrofia cerebelosa, ausencia o presencia de alteraciones de la intensidad de señal y localizaciones de las mismas), ayudarán al clínico a establecer unas determinadas sospechas diagnósticas, que siempre procurará confirmar con la detección de la mutación genética causal. El hallazgo de la mutación es decisivo para establecer el pronóstico y consejo genético, además permitirá indicar un tratamiento eficaz en determinadas entidades (abetalipoproteinemia, ataxia por déficit de vitamina E, enfermedad de Refsum, xantomatosis cerebrotendinosa, enfermedad de Niemann-Pick tipo C, enfermedad de Wilson). Sin diagnóstico genético no será posible realizar investigación básica ni tampoco poner en marcha ensayos terapéuticos
Introduction: Autosomal recessive spinocerebellar ataxia refers to a large group of diseases affecting the cerebellum and/or its connections, although they may also involve other regions of the nervous system. These diseases are accompanied by a wide range of systemic manifestations (cardiopathies, endocrinopathies, skeletal deformities, and skin abnormalities). Development: This study reviews current knowledge of the most common forms of autosomal recessive spinocerebellar ataxia in order to provide tips that may facilitate diagnosis. Conclusions: A thorough assessment of clinical phenotype (pure cerebellar or cerebellar-plus syndrome, with or without systemic manifestations), laboratory tests (vitamin E, acanthocytosis, albumin, cholesterol, phytanic acid, lactic acid, creatine kinase, cholestanol, coenzyme Q10, alpha-fetoprotein, copper, ceruloplasmin, chitotriosidase), nerve conduction studies (presence and type of neuropathy), and an magnetic resonance imaging study (presence of cerebellar atrophy, presence and location of signal alterations) may help establish a suspected diagnosis, which should be confirmed by detecting the underlying genetic mutation. A positive genetic test result is necessary to determine prognosis and provide adequate genetic counselling, and will also permit appropriate treatment of some entities (abetalipoproteinaemia, ataxia with vitamin E deficiency, Refsum disease, cerebrotendinous xanthomatosis, Niemann-Pick disease type C, Wilson disease). Without a genetic diagnosis, conducting basic research and therapeutic trials will not be possible
Asunto(s)
Humanos , Degeneraciones Espinocerebelosas/diagnóstico , Ataxia Cerebelosa/diagnóstico , Ataxias Espinocerebelosas/diagnóstico , Ataxia Telangiectasia/diagnóstico , Enfermedad de Refsum/diagnóstico , Degeneración Hepatolenticular/diagnóstico , Enfermedad de Niemann-Pick Tipo C/diagnóstico , Mutación/genética , Marcadores Genéticos , Comorbilidad , Pruebas Genéticas/métodosRESUMEN
No disponible
Asunto(s)
Humanos , Electrorretinografía/métodos , Enfermedades Neurodegenerativas/diagnóstico por imagen , Pigmentos Retinianos/efectos de la radiación , Electrorretinografía , Lipofuscinosis Ceroideas Neuronales/diagnóstico , Mucolipidosis/diagnóstico , Enfermedad de Refsum/diagnóstico , Diagnóstico DiferencialRESUMEN
Charcot-Marie-Tooth disease type 4D (CMT4D) is an autosomal-recessive demyelinating form of CMT characterized by a severe distal motor and sensory neuropathy. NDRG1 is the causative gene for CMT4D. To date, only four mutations in NDRG1 -c.442C>T (p.Arg148*), c.739delC (p.His247Thrfs*74), c.538-1G>A, and duplication of exons 6-8-have been described in CMT4D patients. Here, using targeted next-generation sequencing examination, we identified for the first time two homozygous missense variants in NDRG1, c.437T>C (p.Leu146Pro) and c.701G>A (p.Arg234Gln), in two Chinese CMT families with consanguineous histories. Further functional studies were performed to characterize the biological effects of these variants. Cell culture transfection studies showed that mutant NDRG1 carrying p.Leu146Pro, p.Arg148*, or p.Arg234Gln variant degraded faster than wild-type NDRG1, resulting in lower protein levels. Live cell confocal microscopy and coimmunoprecipitation analysis indicated that these variants did not disrupt the interaction between NDRG1 and Rab4a protein. However, NDRG1-knockdown cells expressing mutant NDRG1 displayed enlarged Rab4a-positive compartments. Moreover, mutant NDRG1 could not enhance the uptake of DiI-LDL or increase the fraction of low-density lipoprotein receptor on the cell surface. Taken together, our study described two missense mutations in NDRG1 and emphasized the important role of NDRG1 in intracellular protein trafficking.
Asunto(s)
Proteínas de Ciclo Celular/genética , Enfermedad de Charcot-Marie-Tooth/diagnóstico , Enfermedad de Charcot-Marie-Tooth/genética , Estudios de Asociación Genética , Péptidos y Proteínas de Señalización Intracelular/genética , Mutación Missense , Enfermedad de Refsum/diagnóstico , Enfermedad de Refsum/genética , Adolescente , Adulto , Alelos , Sustitución de Aminoácidos , Proteínas de Ciclo Celular/metabolismo , Enfermedad de Charcot-Marie-Tooth/metabolismo , Femenino , Duplicación de Gen , Técnicas de Silenciamiento del Gen , Genotipo , Secuenciación de Nucleótidos de Alto Rendimiento , Humanos , Péptidos y Proteínas de Señalización Intracelular/metabolismo , Masculino , Fenotipo , Unión Proteica , Receptores de LDL/genética , Receptores de LDL/metabolismo , Enfermedad de Refsum/metabolismo , Análisis de Secuencia de ADN , Eliminación de Secuencia , Adulto Joven , Proteínas de Unión al GTP rab4/metabolismoRESUMEN
Hereditary motor and sensory neuropathy-type Lom (HMSNL), also known as CMT4D, a demyelinating neuropathy with late-onset deafness is an autosomal recessive disorder threatening Roma population worldwide. The clinical phenotype was reported in several case reports before the gene discovery. HMSNL is caused by a homozygous founder mutation p.Arg148* in the N-Myc downstream-regulated gene 1. Here, we report findings from the Czech Republic, where HMSNL was found in 12 Czech patients from eight families. In these 12 patients, 11 of the causes were due to p.Arg148* mutation inherited from both parents by the autosomal recessive mechanism. But in one case, the recessive mutation was inherited only from one parent (father) and unmasked owing to an uniparental isodisomy of the entire chromosome eight. The inherited peripheral neuropathy owing to an isodisomy of the whole chromosome pointed to an interesting, less frequent possibility of recessive disease and complications with genetic counseling.
Asunto(s)
Proteínas de Ciclo Celular/genética , Enfermedad de Charcot-Marie-Tooth/genética , Péptidos y Proteínas de Señalización Intracelular/genética , Mutación , Enfermedad de Refsum/genética , Romaní , Disomía Uniparental , Adulto , Edad de Inicio , Enfermedad de Charcot-Marie-Tooth/diagnóstico , Enfermedad de Charcot-Marie-Tooth/etnología , Enfermedad de Charcot-Marie-Tooth/fisiopatología , Niño , Preescolar , Cromosomas Humanos Par 8/química , República Checa , Sordera/fisiopatología , Femenino , Efecto Fundador , Expresión Génica , Genes Recesivos , Asesoramiento Genético , Genotipo , Humanos , Masculino , Fenotipo , Enfermedad de Refsum/diagnóstico , Enfermedad de Refsum/etnología , Enfermedad de Refsum/fisiopatologíaRESUMEN
Because little is known about teacher-student relationships that involve students with acquired deafblindness, the authors performed a multiple case study with a multiple-method design to investigate the relationship between need-supportive teaching behaviors and student engagement. Using self-determination theory (Deci & Ryan, 2000), they analyzed video observations of interactions. It was found that teachers' provision of structure, autonomy support, and involvement often cooccurs with higher levels of student engagement. Moreover, varying degrees of need support over time seem to result in varying levels of student engagement. Examples are provided of need-supportive teaching behaviors that can be used to foster the motivation of students with acquired deafblindness.
Asunto(s)
Síndrome de Retracción de Duane/psicología , Educación de Personas con Discapacidad Auditiva/métodos , Educación de Personas con Discapacidad Visual/métodos , Relaciones Interpersonales , Motivación , Personas con Deficiencia Auditiva/psicología , Enfermedad de Refsum/psicología , Maestros/psicología , Síndromes de Usher/psicología , Personas con Daño Visual/psicología , Adolescente , Conducta del Adolescente , Síndrome de Retracción de Duane/diagnóstico , Femenino , Humanos , Autonomía Personal , Enfermedad de Refsum/diagnóstico , Enseñanza , Síndromes de Usher/diagnóstico , Grabación en VideoRESUMEN
Peroxisomal disorders are a heterogeneous group of genetic metabolic disorders, caused by a defect in peroxisome biogenesis or a deficiency of a single peroxisomal enzyme. The peroxisomal disorders include the Zellweger spectrum disorders, the rhizomelic chondrodysplasia punctata spectrum disorders, X-linked adrenoleukodystrophy, and multiple single enzyme deficiencies. There are several core phenotypes caused by peroxisomal dysfunction that clinicians can recognize. The diagnosis is suggested by biochemical testing in blood and urine and confirmed by functional assays in cultured skin fibroblasts, followed by mutation analysis. This review describes the phenotype of the main peroxisomal disorders and possible pitfalls in (laboratory) diagnosis to aid clinicians in the recognition of this group of diseases.
Asunto(s)
Trastorno Peroxisomal/diagnóstico , Adrenoleucodistrofia/sangre , Adrenoleucodistrofia/diagnóstico , Edad de Inicio , Biomarcadores/sangre , Condrodisplasia Punctata Rizomélica/sangre , Condrodisplasia Punctata Rizomélica/diagnóstico , Análisis Mutacional de ADN , Genotipo , Humanos , Trastorno Peroxisomal/sangre , Fenotipo , Racemasas y Epimerasas/deficiencia , Enfermedad de Refsum/sangre , Enfermedad de Refsum/diagnóstico , Síndrome de Zellweger/sangre , Síndrome de Zellweger/diagnósticoRESUMEN
Hereditary motor and sensory neuropathy type Russe (HMSNR), also called CMT4G, is an autosomal recessive inherited peripheral neuropathy (IPN) caused by a founder mutation in the HK1 gene. HMSNR affects only patients with Roma origin, similar to the better known HMSN type Lom clarified earlier. By testing IPN patients with Roma origin, we realized that HMSNR affects surprisingly many patients in the Czech Republic. HMSNR is one of the most frequent types of IPN in this country and appears to be twice more frequent than HMSNL. Pronounced lower limb atrophies and severe deformities often lead to walking inability in even young patients, but hands are usually only mildly affected even after many years of disease duration. The group of 20 patients with HMSNR presented here is the first report about the prevalence of HMSNR from central Europe.
Asunto(s)
Enfermedad de Charcot-Marie-Tooth/genética , Efecto Fundador , Neuropatía Hereditaria Motora y Sensorial/genética , Hexoquinasa/genética , Mutación , Enfermedad de Refsum/genética , Romaní , Adolescente , Adulto , Enfermedad de Charcot-Marie-Tooth/diagnóstico , Enfermedad de Charcot-Marie-Tooth/etnología , Enfermedad de Charcot-Marie-Tooth/patología , Niño , Preescolar , República Checa , Femenino , Expresión Génica , Genes Recesivos , Haplotipos , Neuropatía Hereditaria Motora y Sensorial/diagnóstico , Neuropatía Hereditaria Motora y Sensorial/etnología , Neuropatía Hereditaria Motora y Sensorial/patología , Heterocigoto , Homocigoto , Humanos , Masculino , Persona de Mediana Edad , Linaje , Enfermedad de Refsum/diagnóstico , Enfermedad de Refsum/etnología , Enfermedad de Refsum/patologíaRESUMEN
PURPOSE: To review and describe findings, pathophysiology, and management of infantile Refsum disease in a young adult, and to compare with those of classic Refsum Disease. METHODS: Retrospective chart and digital photography review. RESULTS: A 25-year-old woman with a diagnosis of infantile Refsum disease presented with progressively decreasing vision. Findings included a noncorpuscular pigmentary degeneration of both fundi, optic nerve head drusen, attenuated retinal vasculature, cataract, myopia, and esotropia. She was treated with a low phytanic acid diet, resulting in improved metabolic values on laboratory testing. CONCLUSION: Infantile Refsum disease has clinical features and a pathophysiology distinct from classic Refsum disease, despite occasionally presenting for examination later in life. Ophthalmic and systemic distinctions between the two are important to consider for the ophthalmologist, who may be involved in the initial diagnosis of the patient.
Asunto(s)
Oftalmopatías/etiología , Enfermedad de Refsum Infantil/complicaciones , Trastornos de la Visión/etiología , Adulto , Diagnóstico Diferencial , Femenino , Humanos , Ácido Fitánico/sangre , Enfermedad de Refsum/diagnóstico , Enfermedad de Refsum Infantil/diagnóstico , Estudios RetrospectivosRESUMEN
Classic Refsum disease (RD) is a rare, autosomal recessively-inherited disorder of peroxisome metabolism due to a defect in the initial step in the alpha oxidation of phytanic acid (PA), a C16 saturated fatty acid with four methyl side groups, which accumulates in plasma and lipid enriched tissues (please see van den Brink and Wanders, Cell Mol Life Sci 63:1752-1765, 2006). It has been proposed that the disease complex in RD is in part due to the high affinity of phytanic acid for retinoid X receptors and peroxisome proliferator-activated receptors. Structurally, epidermal hyperplasia, increased numbers of cornified cell layers, presence of cells with lipid droplets in stratum basale and reduction of granular layer to a single layer have been reported by Blanchet-Bardon et al. (The ichthyoses, SP Medical & Scientific Books, New York, pp 65-69, 1978). However, lamellar body (LB) density and secretion were reportedly normal. We recently examined biopsies from four unrelated patients, using both OsO4 and RuO4 post-fixation to evaluate the barrier lipid structural organization. Although lamellar body density appeared normal, individual organelles often had distorted shape, or had non-lamellar domains interspersed with lamellar structures. Some of the organelles seemed to lack lamellar contents altogether, showing instead uniformly electron-dense contents. In addition, we also observed mitochondrial abnormalities in the nucleated epidermis. Stratum granulosum-stratum corneum junctions also showed co-existence of non-lamellar and lamellar domains, indicative of lipid phase separation. Also, partial detachment or complete absence of corneocyte lipid envelopes (CLE) was seen in the stratum corneum of all RD patients. In conclusion, abnormal LB contents, resulting in defective lamellar bilayers, as well as reduced CLEs, likely lead to impaired barrier function in RD.
Asunto(s)
Gotas Lipídicas/ultraestructura , Enfermedad de Refsum/patología , Piel/ultraestructura , Anciano , Biopsia , Femenino , Humanos , Metabolismo de los Lípidos/genética , Microscopía Electrónica , Persona de Mediana Edad , Oxigenasas de Función Mixta/genética , Mutación/genética , Receptor de la Señal 2 de Direccionamiento al Peroxisoma , Receptores Activados del Proliferador del Peroxisoma/metabolismo , Receptores Citoplasmáticos y Nucleares/genética , Enfermedad de Refsum/diagnóstico , Enfermedad de Refsum/genética , Piel/metabolismoRESUMEN
OBJECTIVE: Peroxisomal blood tests are generally considered to be conclusive. We observed several patients with a clinical and MRI phenotype suggestive of an infantile onset peroxisomal defect, but no convincing abnormalities in initial peroxisomal blood tests. Brain MRI showed typical abnormalities as observed in the neonatal adrenoleukodystrophy variant of infantile peroxisomal disorders. Our aim was to evaluate the accuracy of this MRI diagnosis with further peroxisomal testing. METHODS: We searched our database of unclassified leukoencephalopathies and found 6 such patients. We collected clinical data and scored available MRIs of these patients. We performed further peroxisomal studies in fibroblasts, including immunofluorescence microscopy analysis with antibodies against catalase, a peroxisomal matrix enzyme. We performed complementation analysis and analyzed the suspected genes. RESULTS: We confirmed the diagnosis of Zellweger spectrum disorder in 3 patients and D-bifunctional protein deficiency in the others. The clinical findings were within the spectrum known for these diagnoses. Sequential MRIs showed that the abnormalities started in the hilus of the dentate nucleus and superior cerebellar peduncles. Subsequently, the cerebellar white matter and brainstem tracts were affected, followed by the parieto-occipital white matter, splenium of the corpus callosum, and posterior limb of the internal capsule. Eventually, all cerebral white matter became abnormal. The thalamus was typically affected as well. CONCLUSIONS: If MRI reveals abnormalities suggestive of infantile onset peroxisomal defects, negative peroxisomal blood tests do not exclude the diagnosis. Further tests in fibroblasts should be performed, most importantly immunofluorescence microscopy analysis with antibodies against catalase to stain peroxisomes.
Asunto(s)
Encéfalo/patología , Imagen por Resonancia Magnética , Trastorno Peroxisomal/diagnóstico , Tronco Encefálico/patología , Núcleos Cerebelosos/patología , Cerebelo/patología , Preescolar , Cuerpo Calloso/patología , Diagnóstico Diferencial , Fibroblastos/patología , Humanos , Recién Nacido , Cápsula Interna/patología , Masculino , Enfermedad de Refsum/diagnóstico , Estudios Retrospectivos , Síndrome de Zellweger/diagnósticoRESUMEN
Adult Refsum disease is characterized by an elevated plasma phytanic acid level and high concentrations of phytanic acid in a variety of tissues. Besides tapetoretinal degeneration, additional symptoms are anosmia, skeletal malformations, chronic polyneuropathy, cerebellar ataxia, sensorineural hearing loss, ichthyosis, and cardiac abnormalities. A diet low in phytanic acid ameliorates polyneuropathy and ataxia and slows or even stops the other manifestations. In order to be able to apply dietary therapy, as many patients as possible (even better if all of them are) have to be identified at an early stage. The ophthalmologist plays a crucial role in achieving this goal because of the early manifestation of the tapetoretinal degeneration.
Asunto(s)
Enfermedad de Refsum , Retinitis Pigmentosa , Adulto , Humanos , Ácido Fitánico/sangre , Enfermedad de Refsum/diagnóstico , Enfermedad de Refsum/terapia , Retinitis Pigmentosa/diagnóstico , Retinitis Pigmentosa/etiología , Retinitis Pigmentosa/terapiaRESUMEN
BACKGROUND: Patients with peroxisomal biogenesis disorders (PBDs) have an abnormal profile of circulating acylcarnitines (i.e. elevated C16:0-DC-, C18:0-DC-, C24:0-, C26:0-carnitine). We developed an ESI-MS/MS method for quantification of urine acylcarnitines and tested its reliability for the diagnosis of PBDs. METHODS: Urine from 7 patients with PBDs (5 Zellweger syndrome, 2 infantile Refsum disease), from 2 patients with D-bifunctional protein (D-BP) deficiency, and from 130 healthy controls were analysed by ESI-MS/MS, using a multiple reactions monitoring (MRM) method, and quantified with labelled internal standards. Acylcarnitine levels between groups were analyzed by the STATA statistics data analysis and compared by the non parametric Mann-Whitney test. RESULTS: In PBDs, the urinary excretion of long-chain dicarboxylylcarnitines (C14:0-DC-, C16:0-DC-, and C18:0-DC-carnitine), and of very long-chain monocarboxylylcarnitines (C22:0-, C24:0-, C26:0-carnitine) were significantly elevated compared to controls (p<0.0001). Interestingly, among PBDs the most severe abnormalities of acylcarnitine profile were observed in patients with Zellweger syndrome. One patient with D-BP showed similar abnormalities to PBDs, while in the other only C16:0-DC-carnitine was markedly elevated. CONCLUSIONS: This study shows that MRM ESI-MS/MS acylcarnitine analysis unequivocally discriminates patients with PBDs and D-BP deficiency from controls, representing a reliable and sensitive method for the diagnosis that requires a short-time analysis with high sample through-put.
Asunto(s)
Carnitina/análogos & derivados , Trastorno Peroxisomal/diagnóstico , Trastorno Peroxisomal/orina , Carnitina/orina , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Enfermedad de Refsum/diagnóstico , Enfermedad de Refsum/orina , Reproducibilidad de los Resultados , Espectrometría de Masa por Ionización de Electrospray , Espectrometría de Masas en Tándem , Síndrome de Zellweger/diagnóstico , Síndrome de Zellweger/orinaRESUMEN
Alpha-methylacyl-CoA racemase (AMACR) deficiency is a rare disorder of fatty acid metabolism which has recently been described in three adult cases. We have identified a further patient with clinical features of a relapsing encephalopathy, seizures and cognitive decline over a 40 year period. Biochemical studies revealed grossly elevated plasma pristanic acid levels, and a deficiency of AMACR in skin fibroblasts. Sequence analysis of AMACR cDNA identified a homozygous point mutation (c154T>C). This case adds to the phenotypic variation seen in this peroxisomal disorder and highlights the importance of screening for plasma pristanic acid levels in patients with unexplained relapsing encephalopathies.
Asunto(s)
Encefalopatías Metabólicas Innatas/diagnóstico , Encefalopatías Metabólicas Innatas/genética , Demencia/diagnóstico , Demencia/genética , Ácidos Grasos/sangre , Trastornos Heredodegenerativos del Sistema Nervioso/diagnóstico , Trastornos Heredodegenerativos del Sistema Nervioso/genética , Trastorno Peroxisomal/diagnóstico , Trastorno Peroxisomal/genética , Racemasas y Epimerasas/deficiencia , Enfermedad de Refsum/diagnóstico , Enfermedad de Refsum/genética , Sustitución de Aminoácidos/genética , Encéfalo/patología , Corteza Cerebral/patología , Femenino , Regulación Enzimológica de la Expresión Génica/fisiología , Homocigoto , Humanos , Imagen por Resonancia Magnética , Persona de Mediana Edad , Examen Neurológico , Pruebas Neuropsicológicas , Fenotipo , Mutación Puntual/genética , Recurrencia , Análisis de Secuencia de ADNRESUMEN
The biochemical hallmark of adult Refsum disease (ARD) is an isolated deficiency in the breakdown of phytanic acid. This usually results from a PHYH gene defect, although some cases have been found to carry a PEX7 defect. We describe the phenotype of such a patient, indistinguishable from that of classic ARD. Hence, we propose the subdivision of ARD into type 1 and type 2, depending on which gene is defective.
Asunto(s)
Fenotipo , Receptores Citoplasmáticos y Nucleares/genética , Enfermedad de Refsum/diagnóstico , Enfermedad de Refsum/genética , Anciano , Análisis Mutacional de ADN , Predisposición Genética a la Enfermedad/genética , Humanos , Masculino , Mutación , Receptor de la Señal 2 de Direccionamiento al Peroxisoma , Enfermedad de Refsum/clasificaciónRESUMEN
Autosomal recessive cerebellar ataxias (ARCA) are a heterogeneous group of rare neurological disorders involving both central and peripheral nervous system, and in some case other systems and organs, and characterized by degeneration or abnormal development of cerebellum and spinal cord, autosomal recessive inheritance and, in most cases, early onset occurring before the age of 20 years. This group encompasses a large number of rare diseases, the most frequent in Caucasian population being Friedreich ataxia (estimated prevalence 2-4/100,000), ataxia-telangiectasia (1-2.5/100,000) and early onset cerebellar ataxia with retained tendon reflexes (1/100,000). Other forms ARCA are much less common. Based on clinicogenetic criteria, five main types ARCA can be distinguished: congenital ataxias (developmental disorder), ataxias associated with metabolic disorders, ataxias with a DNA repair defect, degenerative ataxias, and ataxia associated with other features. These diseases are due to mutations in specific genes, some of which have been identified, such as frataxin in Friedreich ataxia, alpha-tocopherol transfer protein in ataxia with vitamin E deficiency (AVED), aprataxin in ataxia with oculomotor apraxia (AOA1), and senataxin in ataxia with oculomotor apraxia (AOA2). Clinical diagnosis is confirmed by ancillary tests such as neuroimaging (magnetic resonance imaging, scanning), electrophysiological examination, and mutation analysis when the causative gene is identified. Correct clinical and genetic diagnosis is important for appropriate genetic counseling and prognosis and, in some instances, pharmacological treatment. Due to autosomal recessive inheritance, previous familial history of affected individuals is unlikely. For most ARCA there is no specific drug treatment except for coenzyme Q10 deficiency and abetalipoproteinemia.